BB Good human data, but mixed outcomes or surrogate markers. How we grade →Randomized controlled trial (double-blind, placebo) · 237 postmenopausal women, 2 years
A 2-yr randomized controlled trial on creatine supplementation during exercise for postmenopausal bone health
P Chilibeck, D Candow, J Gordon, W Duff, R Mason, K Shaw, R Taylor-Gjevre, et al. Medicine & Science in Sports & Exercise. 2023.
Bottom line: In 237 postmenopausal women who exercised for 2 years, creatine did not change hip or spine bone density or strength compared with placebo.
- In plain language
- This double-blind, placebo-controlled trial enrolled 237 postmenopausal women (mean age 59) for 2 years. They took creatine (0.14 g per kg of body weight a day) or placebo while doing resistance training 3 days a week and walking 6 days a week. Creatine did not change bone density at the femoral neck (the main outcome), total hip or lumbar spine, and did not change bench press or hack squat strength. Some femoral neck shape measures held up better with creatine, 80 m walking time improved (48.6 to 47.1 seconds versus 48.3 to 48.2 on placebo), and lean mass rose more in completers only.
- Limits
- The primary outcome was null, and the bone geometry findings were secondary outcomes; the lean mass gain appeared only in completers. Funded by the Canadian Institutes of Health Research; one author sits on an AlzChem advisory board.
- Which of our grades it feeds
- AA Multiple randomized trials or meta-analyses, consistent results. How we grade →Science summary: Creatine: strength, muscle and the aging body
- Source
- doi.org/10.1249/mss.0000000000003202 · PubMed 37144634 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. Reviewed . We sell some of what we grade.